Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Nichols

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Current Topics in Microbiology and Immunology|July 22, 1998
Diphtheria toxin fusion proteinsF M Foss, M N Saleh, J G Krueger, et al.
The Biochemical Journal|November 20, 1998
Conformationally variable Rab protein surface regions mapped by limited proteolysis and homology modellingL Nikolova, K Soman, J C Nichols, et al.
The Journal of Clinical Investigation|February 1, 1993
Prevention of smooth muscle cell outgrowth from human atherosclerotic plaque by a recombinant cytotoxin specific for the epidermal growth factor receptorJ G Pickering, P A Bacha, L Weir, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivoV E Kelley, P Bacha, O Pankewycz, et al.
International Journal of Cancer|August 19, 1991
Impact of interleukin-2-receptor-targeted cytotoxins on a unique model of murine interleukin-2-receptor-expressing malignancyP A Bacha, S E Forte, D M McCarthy, et al.
Transplantation Proceedings|March 20, 1999
Glycine rinse protects against liver injury during transplantationA S Arora, J C Nichols, M DeBernardi, et al.
Targeted Diagnosis and Therapy|January 1, 1992
In vivo studies with chimeric toxins. Interleukin-2 fusion toxins as immunosuppressive agentsM E Shapiro, R L Kirkman, V R Kelley, et al.
Mayo Clinic Proceedings|September 1, 1993
Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitisJ C Nichols, G J Gores, N F LaRusso, et al.
Annals of the New York Academy of Sciences|December 30, 1991
DAB486IL-2 (IL-2 toxin) selectively inactivates high-affinity IL-2 receptor-bearing human peripheral blood mononuclear cellsC A Waters, C E Snider, K Itoh, et al.
Psychiatric Medicine|June 1, 1984
Propranolol and depression: a reevaluation based on a pilot clinical trialA Stoudemire, J T Brown, R T Harris, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Current Topics in Microbiology and Immunology|July 22, 1998
Diphtheria toxin fusion proteinsF M Foss, M N Saleh, J G Krueger, et al.
The Biochemical Journal|November 20, 1998
Conformationally variable Rab protein surface regions mapped by limited proteolysis and homology modellingL Nikolova, K Soman, J C Nichols, et al.
The Journal of Clinical Investigation|February 1, 1993
Prevention of smooth muscle cell outgrowth from human atherosclerotic plaque by a recombinant cytotoxin specific for the epidermal growth factor receptorJ G Pickering, P A Bacha, L Weir, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivoV E Kelley, P Bacha, O Pankewycz, et al.
International Journal of Cancer|August 19, 1991
Impact of interleukin-2-receptor-targeted cytotoxins on a unique model of murine interleukin-2-receptor-expressing malignancyP A Bacha, S E Forte, D M McCarthy, et al.
Transplantation Proceedings|March 20, 1999
Glycine rinse protects against liver injury during transplantationA S Arora, J C Nichols, M DeBernardi, et al.
Targeted Diagnosis and Therapy|January 1, 1992
In vivo studies with chimeric toxins. Interleukin-2 fusion toxins as immunosuppressive agentsM E Shapiro, R L Kirkman, V R Kelley, et al.
Mayo Clinic Proceedings|September 1, 1993
Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitisJ C Nichols, G J Gores, N F LaRusso, et al.
Annals of the New York Academy of Sciences|December 30, 1991
DAB486IL-2 (IL-2 toxin) selectively inactivates high-affinity IL-2 receptor-bearing human peripheral blood mononuclear cellsC A Waters, C E Snider, K Itoh, et al.
Psychiatric Medicine|June 1, 1984
Propranolol and depression: a reevaluation based on a pilot clinical trialA Stoudemire, J T Brown, R T Harris, et al.
Pageof 4